Applicant, as named in the Orange Book

Salix

Next listed expiry: Apriso on 1 May 2030. 4 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Apriso mesalamine	mesalamine	022301	1 May 2030	patent, carve-out possible
Relistor methylnaltrexone bromide	methylnaltrexone bromide	208271	10 Mar 2031	patent
Uceris budesonide	budesonide	203634	7 Sep 2031	patent
Trulance plecanatide	plecanatide	208745	5 Jun 2034	patent

Products without listed protection (1)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Uceris budesonide	budesonide	205613	open now	no listed protection